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ABSTRACT  
Flavonoid supplementation improves brachial artery flow-mediated dilatation (FMD), but it is 
not known whether flavonoids protect against vascular dysfunction induced by ischemia-
reperfusion (IR) injury and associated respiratory burst. In a randomized, double-blind, placebo-
controlled, crossover study, we investigated whether 4-weeks supplementation with freeze-dried 
Montmorency cherry (MC) attenuated suppression of FMD after IR induced by prolonged 
forearm occlusion. Twelve physically inactive overweight middle-aged men (52.8±5.8y, BMI: 
28.1±5.3kg.m-2) consumed MC (235mg.d-1 anthocyanins) or placebo capsules for 4-weeks, with 
supplementation blocks separated by 4-weeks washout. Pre and post each supplementation 
block, FMD responses and plasma nitrate and nitrite ([NO2
−]) concentrations were measured at 
baseline and 15, 30, and 45min after prolonged (20-min) forearm occlusion. FMD response was 
significantly depressed by the prolonged occlusion (p<0.001). After 45min reperfusion, FMD 
was restored to baseline levels after MC (FMD pre: -30.5±8.4%, post: -0.6±9.5%) but not 
placebo supplementation (FMD pre: -11.6±10.6, post: -25.4±4.0%; condition x supplement 
interaction: p=0.038). Plasma [NO2
−] decreased after prolonged occlusion but recovered faster 
after MC compared to placebo (45min to baseline; MC: pre: -15.3±9.6, post: -6.2±8.1; Placebo: 
pre: -16.3±5.9, post: -27.7±11.1 nmol.L-1; condition x supplement x time interaction: p=0.033). 
Plasma peroxiredoxin concentration ([Prx2]) was significantly higher after MC (pre: 22.8±1.4, 
post: 28.0±2.4 ng.mL-1, p=0.029) but not after placebo supplementation (pre: 22.1±2.2, post: 
23.7±1.5 ng.mL-1). In conclusion, 4-weeks MC supplementation enhanced recovery of 
endothelium-dependent vasodilatation after IR, in parallel with faster recovery of plasma [NO2
−], 
suggesting NO dependency. These protective effects seem to be related to increased plasma 
[Prx2], presumably conferring protection against the respiratory burst during reperfusion. 
 
NEW & NOTEWORTHY This is the first study to demonstrate that four weeks of MC powder 
supplementation exerted protective effects on endothelium-dependent vasodilation after transient 
IR injury in overweight, physically inactive, non-medicated hypertensive middle-aged men. 
These effects seem to be due to increased NO availability as evidenced by higher plasma nitrite 
concentration and peak arterial diameter during the FMD measurement. This may be a 
consequence of increased concentration of peroxiredoxin and other anti-oxidant systems, and 
hence reduced ROS exposure. 
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INTRODUCTION  
Cardiovascular diseases (CVD) remain the leading worldwide cause of death with an estimated 
17.3 million deaths in 2008, which is projected to increase to 23 million by 2030 (27). Higher 
consumption of fruit and vegetables is associated with a lower risk of all-cause mortality, 
particularly cardiovascular disease mortality (43). Epidemiological data suggest that polyphenols 
within fruits and vegetables may contribute to this observed reduction in CVD risk (4, 13). 
Specifically, a systematic review of prospective cohort studies found that the dietary intake of 
different classes of flavonoids including flavonols, flavones, flavanones, flavan-3-ols, 
anthocyanidins and proanthocyanidins significantly decreased the risk of CVD (44). Risk factors 
for CVD including hypertension, hypercholesterolemia and diabetes mellitus are associated with 
enhanced production of reactive oxygen species (ROS), particularly superoxide, generated by 
enzymes such as xanthine oxidase and NADPH oxidase (NOX) and via the electron transport 
chain, which induce oxidative stress in the vascular wall, and endothelial dysfunction (29). 
Ischaemia reperfusion injuries are relatively common vascular events during general surgical 
procedures, and present a significant problem for organ transplant. For instance, myocardial 
injury was experienced by 19% of individuals aged over 45y after non-cardiac surgery in 
vascular surgical patients, with the majority of these events clinically silent (7). Despite this 
incidence level, and the significant tissue damage resulting from ischaemia reperfusion leading 
to irreversible pathophysiology such as myocardial infarction and stroke, the availability/efficacy 
of therapeutic strategies is still poor.  
Rodriguez-Mateos et al. (38) found that acute blueberry supplementation (766 mg of total 
polyphenols) increased FMD in healthy young men, peaking 1 and 6 hours post-consumption, 
which paralleled the reduction in neutrophil NOX activity. Acute Montmorency cherry (MC) 
consumption (74 mg anthocyanin, 179 mg total polyphenols) significantly lowered systolic blood 
pressure in tandem with increases in circulating phenolic acids (22). A number of studies have 
also found improvements in endothelial dependent vasodilatation after chronic supplementation 
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with fruit polyphenols especially amongst study populations with impaired cardiovascular 
function. Grape juice supplements have been shown to improve FMD in patients with coronary 
artery disease (56 days, Chou 2011) and patients with hypercholesterolaemia (14 days, Coimbra 
2005). Red grapes (72 g/day for 21 days) reduced the suppression of FMD induced by a high fat 
meal (Chaves et al, 2009), grape polyphenols improved FMD in patients with metabolic 
syndrome (267 mg polyphenols for 30 days, Barona et al, 2012) and grape seed extract (2 g/day 
for 4 weeks) improved FMD in patients with increased CVD risk (Clifton 2004). Chokeberry 
juice supplementation (1g polyphenols/day) for 6 weeks also increased FMD in patients with 
hypercholesterolaemia (Poreba et al 2009), and Khan et al. (24) found that blackcurrant 
polyphenol supplementation for 6 weeks (815 mg polyphenols including 143 mg anthocyanins 
per day) improved FMD in healthy adults consuming 2 or fewer portions of fruit and vegetables 
per day.  Consumption of blueberry, cherry and blackcurrant polyphenols appear to enhance 
vascular function (22, 24, 38), most likely through reduced ROS exposure and hence increased 
NO bioavailability (40, 47). Although, not all studies have shown favourable effects, for example 
chronic supplementation (2 – 6 weeks) with grape seed extract (0.6 – 1g/day) had no effect on 
FMD in patients with Type 2 diabetes (Kar et al, 2009), participants with elevated CVD risk 
(although baseline brachial artery diameter was increased, Mellen et al, 2010) and healthy young 
men (van Mierlo et al 2010). 
To date, only one study has investigated whether polyphenol supplementation preserved 
endothelium-dependent vasodilatation after exposure to prolonged forearm occlusion in healthy 
adults (39). Schreuder et al. (39) found that after a 7-day period consuming 3 cups of black tea 
per day (~900 mg total polyphenols) FMD was enhanced 90 min after consumption of ~600 mg 
black tea polyphenols, but FMD was not preserved 20 min after prolonged forearm occlusion. 
However, prior chronic supplementation with both blueberry polyphenols (2) and cherry 
polyphenols (5) reduced IR-induced infarct size, better preserved cardiac function and protected 
against post-ischemic cardiac remodeling in isolated rat hearts. Collectively, these data suggest 
that a longer period of cherry or berry polyphenol supplementation may be necessary to provide 
vaso-protection against IR injury, or that effects may be more likely to be observed in a study 
population with elevated cardiovascular risk factors.  We hypothesized therefore that 4 weeks of 
Montmorency cherry supplementation would increase endogenous antioxidant capacity and thus 
improve FMD and protect against the impairment in endothelial-dependent vasodilation induced 
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by ischemia reperfusion. We adopted an experimental model of a prolonged (20-min) occlusion 
of the forearm that induces a short-lasting impairment to flow mediated dilatation (FMD) (14, 
31), and provides an in vivo model of transient IR injury. We recruited a non-medicated, 
physically inactive, overweight, hypertensive, middle aged male population to take part in the 
study. 
  
MATERIALS AND METHODS 
Participants. Twelve physically inactive, middle-aged male participants (age: 52.8±5.8 y, 
BMI: 28.1±5.3 kg.m-2, Table 1) completed the trials, from a total of fourteen participants 
recruited from local residents in Devon, United Kingdom by Aboo-Bakkar. All participants were 
non-smokers, with no known history of diabetes, cardiovascular diseases, bone or joint problems, 
and were not taking any drugs or nutritional supplements as assessed by questionnaires. Habitual 
physical activity was assessed using the International Physical Activity Questionnaire, and if 
completing <150 min moderate or vigorous activity were deemed to meet the physically inactive 
inclusion criterion. The study was approved by the University of Exeter Research Ethics 
Committee (2013/409) and conformed with the Declaration of Helsinki. All participants 
provided their written informed consent before taking part. Two participants withdrew from the 
study after baseline measurements were completed, but prior to commencing supplementation. 
Study design. The study used a double-blind, randomized crossover design with 2 
experimental arms and a washout period of ≥ 4 weeks (Figure 1). Each of the participants was 
randomly assigned by Bowtell using a sealed opaque envelope system to receive either MC 
capsule in the first supplementation block followed by placebo or vice versa and were scheduled 
to attend the laboratory for 4 trial visits. Participants and the research team involved in 
performing the data analysis remained blind to treatment until all analysis was completed. 
Baseline measurements prior to each supplementation block were made during visits 1 and 3, 
followed by the 4-week supplementation blocks and post supplementation measurements were 
made in visits 2 and 4. The participants consumed either 1.7 g MC powder per day for 28 days in 
the form of 6 capsules (226 mg anthocyanins and 456 mg total phenolics measures as gallic acid 
equivalents, CherryActive Ltd, Sunbury, UK) or placebo capsules (glucose). Three capsules 
were consumed in the morning and three in the evening, with the last dose taken the evening 
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prior to the post-supplementation measures. In line with previous studies (10, 21, 42) there was 
at least a 4-week washout period between trials.  
Experimental Protocol. Participants reported to the laboratory at 08:00 a.m. on each visit, 
preceded by an overnight fast (≥10 h) and having abstained from alcohol and caffeine for more 
than 24 h.  Participants were asked to avoid food and beverages containing high phenolic 
compounds and record their diet for 2 consecutive days immediately prior to their first laboratory 
visit, and to replicate this for 2 days prior to subsequent visits. Diet diaries were analysed using 
Nutritics software and data presented in (Table 2). Upon arrival, a cannula was placed in the 
antecubital vein of the left arm; the same arm upon which FMD measurements were made. Trials 
were conducted in a quiet room with dim light and room temperature set at 24 C.  Participants 
rested in a supine position for 10 min, before baseline FMD was assessed in the left arm with the 
cuff placed just below the elbow. Fifteen min after the baseline FMD measurement, the cuff was 
inflated to 200 mmHg (Hokanson, Bellevue, WA) for 20 min to induce transient ischemia, and 
then FMD measures were repeated after 15, 30 and 45 min of reperfusion. Venous blood samples 
were obtained at baseline, immediately, 2, 4, 15, 30 and 45 min after the 20-min occlusion 
(Figure 2). Blood samples at 15, 30 and 45 min were collected immediately after cuff release for 
FMD measurement. Samples were centrifuged at 4,000 rpm and 4°C for 10 min, within 1 min of 
collection. Plasma was subsequently extracted and immediately frozen at −80°C for later 
analysis for nitrite (NO2
−), nitrate (NO3
−), interleukin 6 (IL6), C reactive protein (CRP), protein 
carbonyl (PC), peroxiredoxin 2 (Prx2) content and catalase (CAT) activity. 
Brachial artery FMD. Brachial artery FMD was examined in the left arm, with the arm 
extended and positioned at an angle of approximately 80 from the torso. Three 
electrocardiogram (ECG) electrodes were positioned on the left and right intraclavicular fossa 
and left iliac crest region respectively. A high-resolution ultrasonography system (Sequoia 512, 
Acuson; Siemens) with a 13-MHz linear array transducer was used to image the brachial artery 
in the distal one-third of the upper arm in accordance with the established protocol in our 
laboratory (8, 9) and recent guidelines (41). To ensure arm stability and transducer placement, a 
customized arm rest and transducer holder device cradled the arm and locked the transducer in 
the position providing the optimal image of the brachial artery. Ultrasound parameters were set 
to optimize the longitudinal B-mode images of the lumen–arterial wall interface and were then 
held stable for a 1-min baseline recording of the image and Doppler velocity. Continuous 
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Doppler velocity assessment was collected using a 60 insonation angle, which did not vary 
during each study. The occlusion cuffs were inflated to 250 mm Hg to completely block the 
arterial inflow for 5 min. Diameter and flow recordings resumed 30 s before cuff deflation and 
continued for 3 min thereafter. All FMD analyses were performed by the same investigator who 
was blind to condition. Ultrasound images triggered at the beginning of the R-wave that marks 
the end of the diastolic phase were captured and then analyzed off-line using a validated ECG-
gating software (Brachial Analyzer, 5 vascular devices, Medical Imaging Applications, 
Coralville, IA). The region of interest was carefully defined and frame-by-frame analysis of 
artery diameter (mm) and blood flow velocity (m/s) was performed by the same analyst. Baseline 
diameter was calculated as the mean of the artery diameter from a 1-min baseline recording 
before each cuff inflation. Peak diameter was determined as the highest artery diameter 
measurements after each cuff deflation. Endothelium-dependent vasodilation was calculated as 
the percentage increase in arterial diameter after a 5-min ischemic stimulus. The total shear rate 
under the curve (SR AUC) was calculated as the area under the shear curve versus time 
immediately after cuff deflation until peak arterial diameter (41).  
 
Plasma nitrite and nitrate concentration. All glassware, utensils, and surfaces were 
rinsed with deionized water to remove residual [NO2
−] and [NO3
−] before blood analyses. The 
undiluted (nondeproteinized) and deproteinized plasma was used to analyze [NO2
−] and [NO3
−] 
respectively using a Sievers gas-phase chemiluminescence NO analyzer (NOA; Sievers NOA 
280i; Analytix, Durham, UK) as described in previous studies (45, 46). 
Plasma Prx2 concentration and CAT activity. Plasma was diluted 16 fold and analyzed 
for [Prx2] using a commercial enzyme-linked immunosorbent assay (ELISA) kit according to the 
manufacturer’s instructions (Cloud-Clone Corp, Texas, USA). For CAT activity, plasma was 
diluted 5 fold and analyzed using a commercial ELISA kit according to the manufacturer’s 
instructions (Cayman Chemical, Michigan, USA). 
Plasma CRP and IL6 concentration. Plasma [CRP] was determined using a turbidometric 
assay on a Siemens Advia 2400 autoanalyser and using commercially available reagents (PZ 
Cormay, Lublin, Poland). Plasma [IL6] concentration was assessed using a commercially 
available ELISA kit (IBL International, Hamburg, Denmark). 
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Plasma PC concentration. Protein content in all plasma samples were measured using 
NanoDrop Lite (Thermo Fisher Scientific Inc, Delaware, USA). Each plasma sample was diluted 
to 10 µg/ml of protein in 1X phosphate buffer saline. The OxiSelect Protein Carbonyl ELISA kit 
(STA-310, Cell Biolabs Inc, California, USA) was used to measure protein carbonyls. Briefly, 
samples were allowed to adsorb to wells of a 96-well plate and then reacted with dinitrophenol 
hydrazine. The protein carbonyls derivatised to dinitrophenyl hydrazone (DNP) were then 
probed with an anti-DNP antibody. The standard curve was prepared from commercially 
prepared reduced and oxidised BSA standards as provided. 
Statistical Analysis. Sample size was based on the power curves for the use of FMD in 
cross-over designs, reported by Donald et al. (16) and the effect size reported by Khan et al (24) 
after polyphenol supplementation. With 80% power, 5% significance and an effect size of 0.8 for 
increase in FMD (24), 12 participants are required in each group. All data are presented as mean 
± standard error of the mean (SEM). FMD, baseline and peak brachial artery diameter, SR AUC, 
plasma [NO2
−] and [NO3
−] were analyzed by 3 way repeated measures ANOVA: condition (MC 
versus placebo) by supplement (pre- versus post-supplementation) by time (FMD measures: 
baseline, 15, 30 and 45 min post-occlusion; plasma nitrate and nitrite measures: 0, 2, 4, 15, 30 
and 45 min post-occlusion). Targeted post hoc two way repeated measures ANOVA were 
completed where significant 3 way interaction effects were identified. Baseline plasma [CRP], 
[IL6], [PC], [Prx2] and CAT activity before and after each supplementation block were analysed 
by 2 way repeated measures ANOVA.  Mauchly’s sphericity test was used to check the 
homogeneity of variance for all ANOVA analyses; when necessary, violations of the assumption 
were corrected with the use of the Greenhouse-Geisser adjustment. Significant main effects were 
followed up with the use of least significant difference post hoc analysis. Data were analyzed 
using statistical software (SPSS Version 19; IBM Corporation, New York, USA), with 
significance accepted as p≤0.05. 
 
RESULTS 
 
Brachial artery FMD. There were no significant differences in baseline FMD values for 
the 4 measurement visits. The FMD response was significantly depressed by the prolonged 
occlusion in all visits (main effect of time: P<0.001; Figure 3) with a significant reduction in 
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FMD 15 and 30 min post-occlusion, but FMD was not significantly different to baseline 45 
minutes after prolonged occlusion. There was a significant condition x supplementation x time 
interaction (P=0.022), whereby 45 min after prolonged occlusion, the FMD response was 
reduced after placebo supplementation but better preserved after MC supplementation (Figure 3). 
Specifically, the magnitude of FMD suppression 45 min after the prolonged occlusion (change 
from baseline FMD to 45 min post occlusion) was significantly attenuated after MC (pre: -
30.5±8.4% vs post: -0.6±9.5%) compared to placebo (pre: -11.6±10.6 vs post: -25.4±4.0) 
supplementation (condition x supplementation interaction: P=0.038). Similarly, there was a 
reduction in SR AUC (main time effect: P<0.001; Table 3) after prolonged occlusion, but there 
was no condition or supplementation effect. Normalization of the FMD data to SR AUC 
(FMD:SR AUC) did not affect the outcome of the analysis (Table 3).  Peak brachial artery 
diameter was significantly suppressed after prolonged occlusion (main time effect, P<0.001). 
There was a condition x supplementation x time interaction (P=0.011; Figure 3), whereby peak 
diameter was higher following prolonged occlusion post versus pre MC supplementation but not 
post versus pre placebo supplementation. In contrast, basal diameter of the brachial artery 
(immediately prior to occlusion for FMD measurement) was increased after the prolonged 
occlusion (main time effect, P<0.001; Figure 3), but there was no condition or supplementation 
effect. 
Plasma analytes. Plasma [NO2
−] and [NO3
−] were significantly depressed by the 
prolonged occlusion in all visits (main effects of time, P<0.001; Table 4). Plasma [NO2
−] 
returned towards baseline during the 45-min recovery after prolonged occlusion more quickly 
after MC supplementation compared to placebo (condition x supplement x time interaction, 
P=0.033, Figure 4). There was no significant effect of supplementation on plasma [NO3
−].  Basal 
plasma [Prx2] was higher after MC (P=0.029) but not after placebo supplementation (Figure 5). 
However, there was no effect of supplementation on basal plasma CAT activity (P>0.05, Figure 
5), or plasma [CRP], [IL6] and [PC] (P>0.05, Table 5).  
 
DISCUSSION 
 
Four weeks MC supplementation enhanced recovery of endothelium-dependent 
vasodilation in overweight, physically inactive, non-medicated hypertensive, middle-aged men 
10 
 
after the transient ischemia-reperfusion injury induced by prolonged forearm occlusion. Plasma 
nitrite concentration was higher after MC supplementation during the recovery period after 
ischemia. Moreover, plasma peroxiredoxin 2 concentration was increased after 4 weeks MC 
supplementation indicating increased capacity for reduction of hydrogen peroxide and therefore 
superoxide quenching. This supports the notion that MC supplementation enhanced NO 
bioavailability and vascular function under conditions of increased ROS generation after 
prolonged blood flow occlusion via increased endogenous antioxidant capacity. 
Prolonged forearm occlusion induced transient IR injury as evidenced by attenuated 
endothelium dependent vasodilation. DeVan et al. (14) reported that FMD in middle-aged 
sedentary subjects was decreased by 68% by the same occlusion protocol employed in the 
present study, while Schreuder et al. (39) and Rakobowchuk et al. (37) reported 33% and 36% 
reductions in FMD 15 minutes after prolonged occlusion in eight healthy women and twenty 
healthy older adults, respectively. In the present study, the reduction in FMD after prolonged 
occlusion appears to be reproducible across trials with FMD approximately 53% lower, 15 min 
after prolonged occlusion when compared to baseline (52±19 %, pre-MC; 58±13 %, pre-placebo;  
49±21 %, post-placebo; and 55±17 %, post-MC respectively). The FMD reduction after 
prolonged occlusion seems to be a consequence of both increased baseline artery diameter (12, 
37, 39) and reduced peak artery diameter (25, 37). It has been suggested that this impaired 
endothelium-dependent vasodilation is due to reduced NO bioavailability as a consequence of 
increased ROS production during reperfusion (17, 35). Our data are consistent with this 
hypothesis, since plasma nitrate and nitrite concentrations were lower in the venous blood exiting 
the forearm subjected to prolonged occlusion. Under normal resting conditions, the rate of 
superoxide production is lower than the flux of NO and this allows effective scavenging of the 
low intracellular levels of hydrogen peroxide and superoxide by anti-oxidant systems including 
PRX2 as well as by NO, resulting in low levels of the cytotoxic derivative, peroxynitrite (18). 
However, during reperfusion immediately after prolonged occlusion, superoxide production is 
increased (35, 42) resulting in greater peroxynitrite formation (30), and reduction in NO 
availability (34, 35). We cannot exclude the possibility that the reduced pH and pO2 induced by 
ischemia enhanced degradation of nitrite to NO (32, 33), which may also contribute to the 
reduction in plasma nitrite concentration observed in the present study.  
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Fruit derived polyphenols improve endothelium dependent vasodilatation, for instance, 
FMD response peaked between 1 to 2 hours, and 6 hours after consuming 766 mg blueberry 
polyphenols (310 mg anthocyanins, (38). Keane et al. (22) showed that systolic blood pressure 
(SBP) was significantly lowered in hypertensive (SBP ≥ 130 mmHg) men 2 h after ingestion of 
60 mL of MC concentrate (74 mg cyanidin-3-glucoside/L, 179 mean gallic acid equivalent/L). 
Chronic supplementation interventions of 4 to 6-weeks with fruit juice or powder (32 – 143 mg 
anthocyanins/day) increased FMD response in men with mild hypercholesterolemia (36) and the 
metabolic syndrome (6), as well as men and women with low fruits and vegetables intake (<2 
portion/day) (24). However, in the present study, 4 weeks of MC powder supplementation 
providing 256 mg.d-1 anthocyanins (split into 2 doses, morning and evening) did not improve 
FMD response in overnight fasted, overweight, physically inactive, non-medicated hypertensive 
middle aged men. Collectively our findings and previous literature suggest that resting vascular 
function is only improved after chronic fruit based supplement consumption in those with 
clinical conditions or low habitual polyphenol intake, but not in those with elevated CVD risk 
factors. However, MC supplementation was able to protect the vasculature from the decline in 
endothelium-dependent vasodilatation induced by ischaemia reperfusion in the present study. 
Polyphenols are suggested to increase calcium-dependent endothelium nitric oxide synthase 
(eNOS) phosphorylation through the phosphatidylinositol 3-kinase-Akt pathway (3) thus 
enhancing NO production. Phenol metabolites such as vanillic acid have also been shown in vivo 
to inhibit NOX activity in neutrophils (38). The resulting reduction in superoxide production and 
hence reduced NO degradation to peroxynitrite will also improve NO bioavailability. 
Anthocyanins and their metabolites have been shown to interact with cysteine residues present in 
Kelch-like ECH-associated protein 1 (Keap1), resulting in nuclear translocation and 
phosphorylation of Nrf2 (20, 26, 28) with subsequent signaling through the antioxidant response 
element pathway to increase production of downstream phase II antioxidant enzymes such as the 
peroxiredoxins (1). The increased plasma PRX2 concentration observed after MC 
supplementation is consistent with this mechanism, and suggests that enhanced capability to 
quench ROS may contribute to the improved NO bioavailability evident in the present study.  
Prolonged forearm occlusion resulted in elevated baseline diameter in all trials in this and 
previous studies (12, 37, 39). This basal dilation might be related to increased endothelium-
derived hyperpolarizing factor (EDHF) production since this pathway is upregulated during 
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eNOS dysfunction, and results in arterial vasodilation via vascular smooth muscle 
hyperpolarization (11). In contrast to the favorable effects of MC supplementation on the NO 
dependent measures (peak brachial artery diameter and plasma nitrite concentration), MC 
supplementation did not influence this NO independent effect on basal brachial artery diameter.  
In conclusion, the results of this randomized placebo-controlled, cross-over study 
demonstrate that four weeks of MC powder supplementation exerted protective effects on 
endothelium-dependent vasodilation after transient IR injury in overweight, physically inactive, 
non-medicated hypertensive middle-aged men. These effects seem to be due to increased NO 
availability as evidenced by higher plasma nitrite concentration and peak arterial diameter during 
the FMD measurement. This may be a consequence of increased concentration of peroxiredoxin 
and other anti-oxidant systems, and hence reduced ROS exposure. 
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Table 1. Participant characteristics. 
Variables  
Age, y 54±1 
Height, cm 179±1 
Weight, kg 91.5±4.0 
Body Mass Index, kg.m-2 28.2±1.6 
Resting Heart Rate, beat/min 66±0 
Systolic Blood Pressure, mmHg 142±6 
Diastolic Blood Pressure, mmHg 88±3 
Values are expressed as mean ± SEM. 
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Table 2. Average dietary composition  
Dietary composition  
Energy (kcal.d-1) 1883 ± 115 
Protein (g.d-1) 74.6 ± 4.1 
Protein (g.kg-1.d-1) 0.9 ± 0.1 
Carbohydrate (g.d-1) 237.8 ± 29.9 
Fat (g.d-1) 66.9 ± 5.5 
Total cholesterol (mg.d-1) 328.5 ± 48.0 
Saturated fat (g.d-1) 23.2 ± 3.1 
Dietary fiber (g.d-1) 16.3 ± 2.2 
Sugars (g.d-1) 77.5 ± 22.4 
Average dietary composition for the 48-h period prior to each trial. Values are expressed 
as mean ± SEM. 
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Table 3. Shear rate area under the curve and FMD normalized to SR AUC  
 Time  
 Baseline 15 min post 30 min post 45 min post 
SR AUC* 
    Placebo 
    
        Pre 663±91 623±63 594±75 629±68 
        Post 683±101 533±60 550±52 579±85 
    Montmorency cherry     
        Pre 669±85 525±58 524±47 577±64 
        Post 632±63 456±54 444±57 544±63 
FMD:SR AUC* 
    Placebo 
    
        Pre 0.99±0.16 0.46±0.06 0.66±0.12 0.85±0.12 
        Post 1.00±0.13 0.67±0.13 0.75±0.10 0.92±0.15 
    Montmorency cherry     
        Pre 0.90±0.09 0.49±0.07 0.65±0.10 0.70±0.11 
        Post 1.06±0.22 0.61±0.09 1.11±0.29 1.15±0.20 
Shear rate area under the curve (SR AUC) and FMD normalized to SR AUC (FMD:SR 
AUC) measured 15 min before 20-min occlusion (baseline), 15, 30 and 45 min after reperfusion, 
before and after each supplementation block. Values are expressed as mean ± SEM, *-main 
effect of time p< 0.001. 
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Table 4. Plasma nitrite [NO2
−] and nitrate [NO3
−] concentrations  
 Time 
 Baseline 0  
min post 
2  
min post 
4  
min post 
15  
min post 
30  
min post 
45 
min post 
 
[NO2−]*# 
(nmol.l-1) 
    Placebo 
       
        Pre 
 
87.3±7.6 63.5±4.2 70.9±3.4 68.3±4.8 72.8±10.8 69.0±5.7 71.0±7.4 
        Post 
 
104.2±13.5 91.3±9.7 86.2±9.1 83.8±11.3 88.7±7.6 82.3±6.5 76.5±6.9 
    MC        
        Pre 
 
82.1±10.0 80.7±11.1 74.2±11.3 71.9±10.1 68.2±14.9 64.2±11.8 66.8±10.1 
         Post 83.2±10.5 65.6±7.3 77.7±8.6 70.2±6.4 81.1±7.3 74.2±9.4 77.0±10.7 
 
[NO3−]* 
(µmol.l-1) 
Placebo 
       
        Pre 
 
32.8±3.9 29.7±3.6 28.6±3.5 28.7±3.3 27.7±2.9 27.9±2.9 27.2±3.0 
        Post 
 
27.3±2.6 25.7±3.0 26.8±3.3 25.9±2.4 25.7±2.7 24.4±2.8 25.8±2.7 
    MC        
        Pre 
 
27.6±4.9 24.8±4.4 26.2±4.7 25.8±4.8 25.6±4.6 25.0±4.5 24.7±4.1 
        Post 
 
29.5±5.2 28.2±4.9 29.3±4.9 27.9±4.9 26.8±4.7 26.6±4.4 26.3±4.4 
Plasma [NO2
−] and [NO3
−] measured 15 min before 20-min occlusion (baseline), and 
immediately, 2, 4, 15, 30 and 45 min after reperfusion, before and after placebo or Montmorency 
cherry (MC) supplementation. Values are expressed as mean ± SEM, *-main effect of time p< 
0.001, #-3 way interaction effect. 
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Table 5. Plasma biomarkers  
 Placebo Montmorency Cherry 
 Pre Post Pre Post 
Interleukin-6 (pg.ml-1) 0.06 ± 0.04 0.06 ± 0.06 0.06 ± 0.03 0.07 ± 0.09 
C Reactive Protein (mg.l-1) 1.01 ± 0.33 3.90 ± 2.69 1.90 ± 0.40 3.40 ± 1.27 
Protein Carbonyl (nmol.mg-1) 0.86 ± 0.11 0.69 ± 0.18 0.93 ± 0.17 0.71 ± 0.10 
Baseline plasma biomarkers before and after 4 weeks of Montmorency cherry and 
placebo supplementation. Values are expressed as mean ± SEM. 
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Figure Legends 
 
Fig. 1. Schematic diagram of study design. 
 
Fig. 2. Brachial artery FMD and venous blood collection before and after prolonged occlusion 
protocol to induce transient IR injury. Arrows represent FMD measurements and blood samples 
for plasma analysis. 
 
Fig. 3. FMD (A, B), baseline diameter (C, D) and peak diameter (E, F) before and after 
prolonged occlusion for placebo (A, C and E) and Montmorency cherry (B, D and F) conditions, 
mean±SEM, n=12. * indicates a significant difference from baseline (main effect for time, 
p<0.05); # indicates a condition vs supplementation vs time interaction (p<0.05).  
 
 
Fig. 4. Change from baseline in plasma nitrite concentrations after prolonged occlusion 
performed pre and post 4 weeks of placebo (A) and MC (B) supplementation, mean±SEM, n=9, 
# - condition x supplement x time interaction: p<0.05. 
 
Fig. 5. Baseline plasma [Prx2] (A) and CAT activity (B) before and after prolonged occlusion 
performed pre and post 4 weeks of placebo and MC supplementation, mean±SEM, n=12, ¥ - 
supplement effect: p<0.05. 
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